News Releases

2003

XXX
Dec.03,2003
Phase I Clinical Study with New HIV Drug (Oral CCR5 Antagonist) Completed in the US (14.5KB)
XXX
Nov.19,2003
Ono and Dong-A Signed a License Agreement on Elaspol® 100 for Injection for Acute Lung Injury (35.6KB)
XXX
Sep.03,2003
Construction of Ono's New Corporate Headquarters Building Completed (6.8KB)
XXX
Jul.15,2003
Clinical Study with New HIV Drug (Oral CCR5 Antagonist)Commenced in the US (37.2KB)
XXX
May.27,2003
Announcement of Termination of Exclusive License Agreement on Sivelestat (Elaspol® 100 for Injection) with Eli Lilly and Company (17.1KB)
XXX
May.16,2003
Ono Pharmaceutical Announces Dissolution of a Subsidiary (8.4KB)
XXX
May.16,2003
Notice regarding Repurchase of Ono Pharmaceutical's Own Shares(Under Article 210 of Japanese Commercial Code) (15.8KB)
XXX
May.16,2003
Notice of Change in Number of Shares in One Trading Unit (8.1KB)
XXX
Apr.04,2003
LossfromRevaluationofSecuritiesfortheFiscalYearEndedMarch31,2003 (23.4KB)
XXX
Feb.19,2003
AnnouncementofDiscontinuationofONO-5816ClinicalStudyforDiabetes (10.7KB)
XXX
Jan.21,2003
Ono Announces Completion of Its Tsukuba Research Institute (16.1KB)
XXX
Jan.16,2003
Ono and GlaxoSmithKline Signed a Worldwide Agreement on Development and Commercialisation of a New HIV Drug (8.2KB)